Why the study?
Does elevated baseline urinary albumin-to-creatinine ratio (UACR) predict the cumulative burden of recurrent worsening heart failure events in ambulatory patients with chronic heart failure?
Does elevated baseline urinary albumin-to-creatinine ratio (UACR) predict the cumulative burden of recurrent worsening heart failure events in ambulatory patients with chronic heart failure?
Elevated UACR is an independent, continuous predictor of recurrent worsening heart failure events in ambulatory chronic heart failure patients, with increased risk detectable even within the conventional normal range (<30 mg/g).
Answers are grounded in this paper and cite their sources.
May aid recurrent WHF risk stratification in chronic HF; extends albuminuria associations below thresholds but leaves therapeutic implications open.
Background Albuminuria reflects cardiorenal vulnerability and has been associated with adverse outcomes in heart failure (HF). However, its relationship with the total burden of recurrent worsening HF (WHF) events in ambulatory patients remains insufficiently defined. Methods We conducted a prospective, multicenter cohort study including 940 ambulatory patients with chronic HF from the Spanish Cardiorenal Registry (derivation cohort) and externally validated the findings in 335 patients attending the Heart Failure Clinic of Hospital Clínico Universitario de Valencia, Valencia, Spain. UACR was measured at baseline and analyzed as <30 vs ≥30 mg/g and as a log-transformed continuous variable. The primary endpoint was total WHF events. Recurrent events were analyzed using negative binomial regression. Results In the derivation cohort (mean age 72 ± 13 years, 36.7% women), the median eGFR and UACR were 54 ml/min/1.73m² (IQR: 37–77) and 20 mg/g (IQR: 10–70), respectively, and 379 patients (40.3%) had UACR values ≥30 mg/g. During a median follow-up of 1.05 years, 477 WHF events occurred in 197 patients. After multivariable adjustment, UACR ≥30 mg/g independently predicted total WHF events (IRR 1.55; 95% CI 1.12–2.15; p = 0.009). Continuous analyses confirmed a graded, non-linear association across the UACR spectrum (p = 0.017). Risk increased continuously across the UACR spectrum with no threshold at 30 mg/g: compared with a UACR of 10 mg/g, a value of 25 mg/g, still within the conventional normal range, was associated with a higher rate of recurrent WHF events (IRR 1.10; 95% CI 1.03–1.18; p = 0.006). Consistent results were obtained in the validation cohort. Conclusions Elevated UACR independently predicts the cumulative burden of recurrent WHF in ambulatory chronic HF, with risk already detectable below the conventional 30 mg/g threshold. Whether measuring UACR improves clinical decision-making requires prospective evaluation.
No takes yet. Share an insight, caveat, or question.
Espriella et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: